With over 10 years of manufacturing experience and thousands of product variations, The Wellness Factory emphasise the need for product quality and efficiency in the manufacturing of wellness goods.

With over 10 years of manufacturing experience and thousands of product variations, The Wellness Factory emphasise the need for product quality and efficiency in the manufacturing of wellness goods. 

The Wellness Factory is dedicated to producing high-quality wellness products, emphasising stringent quality control throughout their processes. Their team of professionals specialise in the manufacturing of various product formats, including powders, tinctures and topicals from inception to product delivery. Known for a comprehensive service that manages the manufacturing, compliance, graphic design and fulfilment of each product, The Wellness Factory tailor their approach to produce market-competitive wellness foods adapted to each clients needs.

By leveraging Opvia’s eQMS, The Wellness Factory has been able to digitise and track their manufacturing across one system. Transitioning to eBR’s (electronic Batch Records) has allowed The Wellness Factory team full traceability of their products. Opvia also facilitates the management of quality documents and compliance records. 

With all information centralised in one platform, Quality Wellness has significantly optimised their manufacturing and quality processes.


Food & Beverage

What to look for in an electronic batch record system?

Liberate your production process from the limits of paper with Opvia's intelligent EBR system. Design, deploy and execute any batch process, all in a single platform. 

Electronic Batch Records (EBR)

Improving Quality Processes with The Wellness Factory

Founded in 2005 and based in Chicago, Illinois, NexTerra is one of the largest premier wine producers outside of California. Partnering with distinguished growers worldwide, NexTerra sources the finest grapes to create unique, exclusive wine blends.

Founded in 2005 and based in Chicago, Illinois, NexTerra is one of the largest premier wine producers outside of California. Partnering with distinguished growers worldwide, NexTerra sources the finest grapes to create unique, exclusive wine blends. 

The state-of-the-art 185,000 square-foot facility houses a winery, bottling systems, and logistical operations, producing up to 2.5 million cases annually. NexTerra offers custom and private label wine services, ensuring a seamless experience from concept to retail shelf.

The NexTerra bottling systems had previously relied on manual paper based systems to record quality control data. Now in partnership with Opvia, the bottling system now leverages a QMS system that allows for immediate document tracking and enhanced traceability.

The introduction of automated workflows and improved quality control in the bottling systems has also enhanced NexTerra's data analysis capabilities. This has allowed for greater data driven insights on each bottling production, while maintaining stringent quality and regulatory standards.


What is a QMS and why should you use one?

Unlock quality and eliminate risk with the Opvia QMS. Connect and manage everything, from documents and deviations to training and data. 

Quality Management (QMS)

Leveraging Digital Quality Systems for Premiere Wine Manufacturing with Nexterra

[Bioventix](https://www.bioventix.com/), based just outside of London, is a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics.

[Bioventix](https://www.bioventix.com/), based just outside of London, is a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics.

Bioventix focuses on the areas of clinical diagnostics and drugs of abuse to identify new or existing commercial assays for which there is or may be a need for improved antibodies, with the aim to provide customers with high quality SMAs that address the shortcomings of other antibodies. Bioventix has successfully developed SMAs to targets where conventional monoclonal or polyclonal antibodies have failed to produce a suitable reagent and supplies antibodies. This advantage over conventional rodent monoclonal antibodies is also reflected in their customer base, which spans a wide range of global multinational immunodiagnostics companies. 

Our antibody technology and laboratory have been based at the in Farnham, Surrey, UK since the 1990s. Their dedicated of scientists, spanning a wide range of scientific capabilities, is committed to providing our customers with innovative solutions to diagnostic challenges. 

The Bioventix team has been using Opvia as its eQMS but have recently expanded its use to Solution Batch Records (SBRs) and Manufacturing Batch Records (MBRs). The quality team is able to manage documentation, deviations, change controls, corrective and preventive actions (CAPAs) in one system. With the expansion to SBRs and MBRs, the Opvia Platform allows full visibility across teams to maintain detailed records, reducing errors and ensuring compliance with regulatory requirements. This streamlined approach simplifies and streamlines their production and quality processes, enhancing overall product and documentation quality.


Biotechnology

5 Tips to Implement a Quality Management System

Speed up the feedback loop from SOP revisions to employee training. 

Document Control

Elevating quality processes at Bioventix

A biotechnology leader since 2010, [Skye Biologics](https://www.skyebiologics.com/) has grown to be one of the world's leading independent new age biotechnology companies, and has reached hundreds of thousands of patients in the US with existing tissue products and is developing a pipeline of medicines with breakaway potential for decades to come.

A biotechnology leader since 2010, [Skye Biologics](https://www.skyebiologics.com/) has grown to be one of the world's leading independent new age biotechnology companies, and has reached hundreds of thousands of patients in the US with existing tissue products and is developing a pipeline of medicines with breakaway potential for decades to come.

Skye Biologics is committed to maximising therapeutic potential by harnessing the power of human biology to treat patients suffering from degenerative disease, damaged tissue, injury, and trauma. Skye is discovering and developing breakthrough therapeutics that optimise the repair process and lead to organised scar free advanced healing. Our novel approach begins with a platform of naturally advanced human biological material from which we unravel the code of complex molecules, isolating and applying them to treat a multitude of conditions. They are dedicated and strive to accelerate to market regenerative solutions that improve health outcomes and dramatically improve people's lives. 

Skye Biologics's tissue implants have been used in over 250,000 tissue-repair treatments nationwide, to augment and support degenerated or damaged tissues in surgical repairs and non-operative therapy as a potential alternative to surgery. Their R&D team continues to work together with leading physicians, institutions, hospitals, to identify medical needs and continue to develop and tailor their unique products and and future biologic therapeutics.

Skye Biologics currently use Opvia for their manufacturing records and quality management system. The integration of these two areas enables them to efficiently track and manage data efficiently and effectively, and enables full visibility across the manufacturing and quality teams. The move to the Opvia platform has allowed Skye Biologics to improve operational efficiency by streamlining the production process and reducing time-to-release from a quality perspective, and tracking of production costs across batches has minimised shortages and overstock situations, thereby reducing costs. 



Why should process manufacturers consider an electronic batch record (EBR) system?

Full visibility across Manufacturing and Quality teams in Skye Biologics

[Ingenza](https://www.ingenza.com/), a leader in engineering biology, is a dynamic CDMO providing preclinical and process development services through to first-in-human manufacturing.

[Ingenza](https://www.ingenza.com/), a leader in engineering biology, is a dynamic CDMO providing preclinical and process development services through to first-in-human manufacturing. Ingenza's understanding of nature, combined with a unique engineering biology toolbox, accelerates customer products through key milestones to commercial success. Its scientific and commercial activities are led by a management team with over 60 years' experience in applied bioscience and the development and commercialisation of bio-based products.

Ingenza spans the disciplines of molecular genetics, biochemistry, fermentation and process/analytical chemistries in Edinburgh, UK. They offer an extensive and unique range of proprietary enabling technologies in microbial strain and mammalian cell-line engineering, protein production, fermentation and bioprocess development. Their bioprocesses, such as bacterial, yeast, and mammalian cell platforms, are implemented worldwide by a wide range of customers, to manufacture (bio)pharmaceuticals, enzymes, chemicals, consumer products and sustainable fuels.

Ingenza uses Opvia for its Quality Management Systems. This partnership is driven by Ingenza's commitment to enhance and centralise its quality management processes, with a focus on precision and operational efficiency. Opvia’s eQMS enables Ingenza to have full traceability and visibility across all quality processes. The quality team is able to manage documents, including Standard Operating Procedures (SOPs), and track deviations, corrective actions (CAPA), and customer complaints in one system. This real-time monitoring system enables quick resolution of quality issues, ensuring compliance with regulatory standards and enhancing overall quality management.


Ingenza selects Opvia as its QMS provider to elevate biotech innovations

Enhancing overall quality management and ensuring compliance with Ingenza 

[IMU](https://www.imubiosciences.com/), based in London, UK, is an innovator in the field of precision immune medicine, dedicated to unlocking the potential of the immune system through deep, systems-level analysis.

[IMU](https://www.imubiosciences.com/), based in London, UK, is an innovator in the field of precision immune medicine, dedicated to unlocking the potential of the immune system through deep, systems-level analysis. 

With its proprietary platform, IMU is pioneering the use of AI and ML analytics to translate vast system level immune data into actionable insights and tools to drive the development of precision medicine across a range of health conditions and treatment responses, aiming to build a comprehensive Immune Atlas that covers the spectrum of health and disease, to advance precision medicine. This technology is the result of ten years of research from King’s College London and was initially applied during the COVID-19 pandemic. 

IMU’s team spans a wide range of healthcare experts, immunologists, technologists, and their laboratories in Canary Wharf offer machines of the latest technology to enable their researchers to make their bold mission a reality.

The IMU team uses Opvia for its intricate needs, covering aspects from lab documentation and experimental workflows to training programmes. Opvia’s system facilitates the rigorous documentation and quality control required to pioneer advancements in immune system profiling and precision medicine.


Opvia partners with IMU Biosciences to support immune profiling innovation

Building a robust QMS with IMU Biosciences

Edinburgh, Scotland - MiAlgae, a trailblazer in sustainable microalgae production for pet food and aquaculture feed, has chosen Opvia as its provider for Electronic Batch Records (EBR), Electronic Lab Notebook (ELN), and Quality Management System (QMS) solutions.


Edinburgh, Scotland - MiAlgae, a trailblazer in sustainable microalgae production for pet food and aquaculture feed, has chosen Opvia as its provider for Electronic Batch Records (EBR), Electronic Lab Notebook (ELN), and Quality Management System (QMS) solutions. This partnership is driven by MiAlgae's commitment to enhancing operational efficiency, innovation and further bolstering its quality processes.\
\
MiAlgae's innovative approach includes the production of omega-3-rich microalgae, offering a sustainable ingredient in petfood and aquaculture feed. Their zero-waste solution repurposes co-products from whisky production to cultivate microalgae while returning clean water, making a substantial contribution to global sustainability efforts.

Opvia's lab and manufacturing quality solutions, including EBR, ELN, and QMS, will empower MiAlgae to optimise production processes, enhance research and data management, and ensure stringent quality control.

Dr Scott Parker, Quality Systems Manager at MiAlgae commented ‘The Opvia platform is helping us to enhance our operational efficiency, enabling us to streamline processes. By optimising our workflows, we've gained valuable time to focus on the science and innovation that will propel us through the next phase of growth.”

Will Moss, CEO at Opvia,stated that “We are excited to be partnering with MiAlgae as their exclusive provider for a suite of lab, manufacturing, and quality control solutions. Opvia is eager to empower MiAlgae with our systems, enabling them to drive innovation and make a positive impact on our planet."

### **About MiAlgae:**

Headquartered in Edinburgh, MiAlage recycles by-products from the local whisky industry to grow microalgae which is turned into NaturAlgae, a dry omega-3 powder with a high concentration of DHA and other oils. NaturAlgae is used to supplement aquafeed, petfood and livestock foods.

MiAlgae was founded in 2016 by Douglas Martin and is committed to its mission to reduce the reliance on wild-caught fish as a source of Omega-3 by harnessing the potential of microalgae as a sustainable and rich alternative source.

### **About Opvia:**

Opvia is a leading provider of R&D, manufacturing, and quality control solutions, offering tailored systems to companies in regulated industries. Opvia empowers companies in the life sciences, chemicals, and manufacturing industries to digitise and optimise their laboratory operations, ensuring compliance, efficiency, and data integrity.

Committed to advancing the frontiers of research and development, Opvia continually tailor its solutions to meet the specific needs and workflows of its partners.


MiAlgae Selects Opvia as Its Trusted Partner for EBR, ELN, and QMS Solutions

Odense, Denmark – **Bioomix**, a Danish biotech company specialising in microbial bio-solutions, has chosen Opvia as its Electronic Lab Notebook (ELN) and data management system provider.


Odense, Denmark – **Bioomix**, a Danish biotech company specialising in microbial bio-solutions, has chosen Opvia as its Electronic Lab Notebook (ELN) and data management system provider. This strategic partnership will enable Bioomix to accelerate innovation as well as efficiently managing their data and processes.

Bioomix stands at the forefront of microbial solution development for agriculture and food sectors. Their pioneering technology facilitates the discovery of natural, beneficial microorganisms. These discoveries are transformed into high-quality fermented biostimulants for the agricultural sector.

Bioomix has selected Opvia as their preferred provider for ELN and data management solutions, recognizing the need for robust and efficient data handling in their cutting-edge research and development processes.

The partnership with Opvia is set to enhance Bioomix's operational efficiency significantly. Opvia's ELN system will provide a unified platform for meticulously capturing, organising, and analysing complex research data. This integration is crucial for Bioomix's unique process of characterising and testing microorganisms, ensuring precision and reliability in their product development.

“We are very pleased with the opportunities Opvia provides us in terms of daily efficiency in our processes”, expressed Mads Asbild, CCO at Bioomix.

Will Moss, CEO at Opvia, stated, “this another step in our ongoing efforts to support the biotechnology sector with advanced lab & data management solutions. Bioomix's work in developing microbial bio-solutions represents the kind of complex, innovative projects our ELN system is designed to facilitate. This partnership is a exciting opportunity for us to contribute to Bioomix's exceptional research in agriculture, food, and health, ensuring that their processes are as cutting-edge as their discoveries."

### About Bioomix:

Bioomix is a bioindustrial company that develops microbial bio-solutions for farmers. We use a new proprietary technology to discover natural beneficial microorganisms. After characterisation and testing, we turn these microorganisms into fermented biostimulant products that contain live and pure microbial strains.

### About Opvia:

Opvia is a leading provider of electronic lab notebook (ELN) and data management solutions, but offering solutions to companies in regulated industries all the way from lab R&D to manufacturing and quality control.

With a focus on traceability, user-friendliness, and customisability, Opvia's ELN system is designed to streamline and enhance the research process. Opvia's platform enables scientists and researchers to efficiently capture, organise, and analyse data, fostering collaboration and accelerating discovery. Committed to advancing the frontiers of research and development, Opvia continually tailor its solutions to meet the specific needs and workflows of its partners.


Bioomix selects Opvia as its ELN Provider to Accelerate Biotech Innovations

Unlock the full potential of your research with our modern ELN, packed with advanced features designed to simplify and accelerate your development journey. From customisable and compliant templates to automated data processing and analytical tools, our platform empowers you to focus on the science.

Electronic Lab Notebook (ELN)

Innovate with purpose. Propel development by joining the AI-driven revolution.

Accelerate innovation and make your lab operations more efficient with our ELN, LIMS, and SDMS solutions, designed to automate workflows, ensure data integrity, and draw out insights with dashboards.

Research & Development

Become agile and data-driven. Rigorously unify your quality operations.

Unlock rigour and agility by unifing your quality operations. Achieve end-to-end traceability, automate workflows and become data-driven with Opvia GxP OS.

Quality

Transform production. Make industry 4.0 a reality across your operations.

Maximise throughput and ensure batch quality with our MES, EBR, and Calibration tools. Designed for automated workflows and complete traceability, they ensure compliance and efficiency.

Trusted by startups and FTSE500s

Learn how companies are using Opvia'